Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Shares Outstanding (Diluted Average) (2017 - 2024)

Historic Shares Outstanding (Diluted Average) for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Sanofi's Shares Outstanding (Diluted Average) rose 390.13% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 390.13%. This contributed to the annual value of $1.3 billion for FY2024, which is 143.32% down from last year.
  • As of Q3 2025, Sanofi's Shares Outstanding (Diluted Average) stood at $1.4 billion, which was up 390.13% from $2705.4 recorded in Q2 2025.
  • Over the past 5 years, Sanofi's Shares Outstanding (Diluted Average) peaked at $1.5 billion during Q1 2021, and registered a low of $1755.3 during Q2 2024.
  • In the last 5 years, Sanofi's Shares Outstanding (Diluted Average) had a median value of $1.3 billion in 2023 and averaged $1.0 billion.
  • As far as peak fluctuations go, Sanofi's Shares Outstanding (Diluted Average) crashed by 6740.72% in 2021, and later surged by 5412.42% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Shares Outstanding (Diluted Average) stood at $1.4 billion in 2021, then decreased by 10.82% to $1.3 billion in 2022, then grew by 5.42% to $1.4 billion in 2023, then dropped by 0.9% to $1.3 billion in 2024, then increased by 6.73% to $1.4 billion in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $1.4 billion for Q3 2025, versus $2705.4 for Q2 2025 and $1.3 billion for Q1 2025.